Fidelity Investments
PDLI

Fidelity Investments’s PDL BioPharma, Inc. PDLI Stock Holding History

Fidelity Investments’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,226
Closed -$10K – 4192
2020
Q2 		$10K Buy
3,226
+652
+25% +$2.06K ﹤0.01% 3124
2020
Q1 		$7K Buy
2,574
+732
+40% +$2.36K ﹤0.01% 3207
2019
Q4 		$6K Buy
1,842
+268
+17% +$778 ﹤0.01% 3388
2019
Q3 		$4K Sell
1,574
-1,134
-42% -$3.03K ﹤0.01% 3469
2019
Q2 		$9K Buy
2,708
+1,133
+72% +$3.67K ﹤0.01% 3267
2019
Q1 		$6K Buy
1,575
+1
+0.1% +$3 ﹤0.01% 3244
2018
Q4 		$5K Sell
1,574
-888,952
-100% -$2.44M ﹤0.01% 3207
2018
Q3 		$2.34M Buy
+890,526
New +$2.19M ﹤0.01% 2338
2018
Q2 		– Sell
-151,780
Closed -$446K – 2808
2018
Q1 		$446K Hold
151,780
– – ﹤0.01% 2528
2017
Q4 		$416K Hold
151,780
– – ﹤0.01% 2543
2017
Q3 		$515K Sell
151,780
-399,689
-72% -$1.11M ﹤0.01% 2477
2017
Q2 		$1.36M Sell
551,469
-382,581
-41% -$880K ﹤0.01% 2398
2017
Q1 		$2.12M Hold
934,050
– – ﹤0.01% 2345
2016
Q4 		$1.98M Buy
934,050
+116,700
+14% +$326K ﹤0.01% 2379
2016
Q3 		$2.74M Buy
817,350
+5,350
+0.7% +$17K ﹤0.01% 2313
2016
Q2 		$2.55M Hold
812,000
– – ﹤0.01% 2335
2016
Q1 		$2.7M Buy
812,000
+65,100
+9% +$203K ﹤0.01% 2309
2015
Q4 		$2.64M Buy
746,900
+373,896
+100% +$1.56M ﹤0.01% 2358
2015
Q3 		$1.88M Buy
373,004
+164,331
+79% +$942K ﹤0.01% 2435
2015
Q2 		$1.34M Buy
208,673
+39,750
+24% +$266K ﹤0.01% 2506
2015
Q1 		$1.19M Buy
168,923
+91,923
+119% +$666K ﹤0.01% 2497
2014
Q4 		$594K Sell
77,000
-13,000
-14% -$103K ﹤0.01% 2614
2014
Q3 		$672K Sell
90,000
-252,621
-74% -$2.35M ﹤0.01% 2591
2014
Q2 		$3.32M Sell
342,621
-17,500
-5% -$156K ﹤0.01% 2321
2014
Q1 		$2.99M Sell
360,121
-898,800
-71% -$7.7M ﹤0.01% 2300
2013
Q4 		$10.6M Hold
1,258,921
– – ﹤0.01% 1948
2013
Q3 		$10M Sell
1,258,921
-5,114,618
-80% -$41.1M ﹤0.01% 1947
2013
Q2 		$49.2M Buy
+6,373,539
New +$49.7M 0.01% 1252

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelity Investments's PDLI Position: Q3 2020 in Review

Fidelity Investments sold out of PDL BioPharma, Inc. (PDLI) in Q3 2020, closing a stake of 3,226 shares — an estimated $10K sold.

Fidelity Investments first reported a position in PDLI in Q2 2013 and held it in 28 quarters. The position peaked at $49.2M in Q2 2013. 132 funds tracked by Wall St. Rank hold PDLI as of Q3 2020.

  • Fidelity Investments reported no remaining PDL BioPharma, Inc. position as of Q3 2020 after selling out during the quarter.
  • Fidelity Investments sold 3,226 PDL BioPharma, Inc. shares in Q3 2020, an estimated $10K.
  • Fidelity Investments first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 28 quarters.
  • Fidelity Investments's PDL BioPharma, Inc. position peaked at $49.2M in Q2 2013.
  • 132 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2020.

Based on Fidelity Investments's 13F filing for Q3 2020, filed 13 Nov 2020.